GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Avinger Inc.
Avinger produces medical devices for the treatment of peripheral arterial disease. Its stock price is a story of its struggle to commercialize its technology. The chart reflects its slow adoption and ongoing need for funding.
Share prices of companies in the market segment - Therapeutic medical equipment
Avinger, Inc. develops and manufactures visualization catheters for the treatment of peripheral arterial disease, helping physicians visualize the inside of the vessel during procedures. We've categorized it as "Therapeutic Medical Equipment." The graph below shows the dynamics in the vascular surgery sector.
Broad Market Index - GURU.Markets
Avinger is a medical device company that develops and markets catheters for the treatment of peripheral arterial disease. As a component of the GURU.Markets index, it represents the medical technology sector. The chart below represents the entire market. See how this company's stock compares to the overall trend.
Change in the price of a company, segment, and market as a whole per day
AVGR - Daily change in the company's share price Avinger Inc.
The daily fluctuations of Avinger, Inc., a manufacturer of medical catheters, reflect the volatility of the MedTech sector. This metric is a measure of sensitivity to sales data, FDA approvals, and clinical results.
Daily change in the price of a set of shares in a market segment - Therapeutic medical equipment
Avinger develops and markets optical coherence tomography-based catheters for the treatment of peripheral arterial disease. This is an innovative medical device sector. The chart below shows the volatility in this niche, allowing one to assess the market acceptance of AVGR technologies.
Daily change in the price of a broad market stock, index - GURU.Markets
Avinger produces medical devices for the treatment of peripheral arterial disease. The medtech company's stock performance depends on the adoption of its technology in surgical practice. Such unique stories are part of a larger market whose overall volatility you can see.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Avinger Inc.
Avinger, Inc.'s year-over-year performance is a story of commercialization of its peripheral artery disease devices. Its 12-month market cap growth reflects its success in selling its Lumivascular catheters, which allow doctors to visualize the inside of an artery during a procedure—a key selling point.
Annual dynamics of market capitalization of the market segment - Therapeutic medical equipment
Avinger, Inc. is a commercial medical device company specializing in the treatment of peripheral arterial disease. This chart illustrates how its innovative yet niche technology and market expansion efforts are impacting its volatile performance in the medical device sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Avinger, a company developing catheters for the treatment of peripheral arterial disease, competes in a large medical device market. Its annual market capitalization dynamics reflect its commercial success, the adoption of its technology by physicians, and its ability to capture market share from larger players.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Avinger Inc.
Avinger is a manufacturer of medical devices for the treatment of peripheral arterial disease. Its monthly growth reflects progress in commercializing its unique technology. Quarterly sales reports and procedure growth are the main drivers.
Monthly dynamics of market capitalization of the market segment - Therapeutic medical equipment
Avinger, Inc. develops visualization-guided catheters for the treatment of peripheral arterial disease. This medical device sector aims to make vascular surgeries less invasive. The chart below shows how investors assessed the prospects of companies offering innovative tools to combat atherosclerosis.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Avinger is a medical device company that produces catheters for the treatment of peripheral arterial disease. It's a commercial company, and its stock price is driven by sales growth and physician adoption of its technology. This is the story of how an innovative device is gaining market share.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Avinger Inc.
Shares of Avinger, Inc., a manufacturer of medical devices for the treatment of peripheral arterial disease, are highly volatile. Weekly price movements depend on news about system sales, clinical data, and funding. The chart below shows how short-term commercial and scientific events impact the valuation of this MedTech startup.
Weekly dynamics of market capitalization of the market segment - Therapeutic medical equipment
Avinger develops catheters for the treatment of peripheral arterial disease. This is an innovative, yet niche technology. The chart shows how sales success and approvals of new devices impact the company's stock, causing it to move independently of medical device giants.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Avinger is a medical technology startup. This chart compares its weekly volatility to the market. It shows how its stock, like other early-stage companies, is driven by news about the adoption of its technology rather than by overall market trends.
Market capitalization of the company, segment and market as a whole
AVGR - Market capitalization of the company Avinger Inc.
The Avinger, Inc. market cap chart reflects its struggle to commercialize its peripheral artery disease devices. This medtech company's market cap illustrates the challenges of gaining widespread medical acceptance and achieving profitability. The dynamics illustrate this challenging path.
AVGR - Share of the company's market capitalization Avinger Inc. within the market segment - Therapeutic medical equipment
Avinger's market share in the therapeutic device sector reflects its unique technology for treating peripheral arterial disease. Its market share is based on its optical coherence tomography catheters, which allow doctors to visualize the inside of an artery during procedures.
Market capitalization of the market segment - Therapeutic medical equipment
Here's a chart of the total market capitalization of developers of medical devices for the treatment of peripheral arterial disease. Avinger is one of the innovators in this niche. The graph shows how the market values technologies that can prevent amputations.
Market capitalization of all companies included in a broad market index - GURU.Markets
This chart depicts the market value of the fight against peripheral artery disease. Avinger, Inc.'s market capitalization is determined by its unique catheter technology that allows for "seeing" inside blood vessels. The line shows how this medical innovation is competing for its share of the future of cardiovascular surgery.
Book value capitalization of the company, segment and market as a whole
AVGR - Book value capitalization of the company Avinger Inc.
This chart illustrates the technological foundation of Avinger, Inc. Its assets include patents and manufactured systems for treating peripheral arterial disease using real-time imaging (Lumivascular). The chart's dynamics show how the company is investing in the development and commercialization of its unique medical technology.
AVGR - Share of the company's book capitalization Avinger Inc. within the market segment - Therapeutic medical equipment
Avinger's tangible assets are its production lines for creating catheters with imaging technology for the treatment of peripheral arterial disease. The chart shows the company's share of this high-tech medical infrastructure, which allows surgeons to "see" inside blood vessels.
Market segment balance sheet capitalization - Therapeutic medical equipment
In the capital-intensive world of medical equipment, Avinger operates at the cutting edge of technology. Its business requires manufacturing capabilities to create its unique catheters, making its model moderately capital-intensive but with a significant intellectual component.
Book value of all companies included in the broad market index - GURU.Markets
Avinger has developed a unique technology for treating peripheral arterial disease using catheters equipped with "vision." The company's assets include the factories that produce these "intravascular eyes." The chart below shows the financial impact of this innovation in vascular surgery.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Avinger Inc.
Avinger develops devices for the treatment of peripheral arterial disease. Its value lies in its unique technology, which allows doctors to "see" inside blood vessels. The chart below is a bet on the commercial success of this approach. Market valuation reflects the technology's potential, not the current asset value.
Market to book capitalization ratio in a market segment - Therapeutic medical equipment
Avinger, Inc. develops catheter-based medical devices for the treatment of peripheral arterial disease. Its value lies in this unique technology. This chart shows how the market valuation, reflecting the potential of its devices, relates to its tangible assets.
Market to book capitalization ratio for the market as a whole
Avinger develops and markets catheter-based medical devices for the treatment of peripheral arterial disease. This chart shows how the market is evaluating their unique Lumivascular technology. The dynamics reflect commercial success and competition in the medical device market.
Debts of the company, segment and market as a whole
AVGR - Company debts Avinger Inc.
Avinger, a company developing medical devices for the treatment of peripheral arterial disease, uses raised capital to fund its commercialization efforts and R&D. This chart shows how the company is vying for market share by investing in its sales force and the development of new generations of its catheters.
Market segment debts - Therapeutic medical equipment
Avinger develops and markets catheter-based medical devices for the treatment of peripheral arterial disease. This chart illustrates how its leverage reflects its challenging commercialization path, requiring significant investment in clinical data and marketing to convince physicians of the benefits of its technology.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Avinger Inc.
Aerovate Therapeutics is a biotech company developing a drug to treat pulmonary arterial hypertension. This chart shows how the company funds its very expensive clinical-stage research. Its future depends entirely on the success of this single key asset.
Market segment debt to market segment book capitalization - Therapeutic medical equipment
Avinger develops and markets catheters for the treatment of peripheral arterial disease. This chart compares its debt to the overall market capitalization of the entire sector. It shows how a small medical device company finances its research, development, and commercial activities.
Debt to book value of all companies in the market
Avinger, Inc. develops and markets catheter-based medical devices for the treatment of peripheral arterial disease. Medtech is a competitive industry. This graph of total market debt helps understand the financial environment in which Avinger is raising capital to commercialize its technology and compete for market share with larger players.
P/E of the company, segment and market as a whole
P/E - Avinger Inc.
This metric for Avinger, a medical device company developing devices for treating peripheral arterial disease, reflects expectations for its technology. The P/E (if any) will be based on investors' belief that its catheters will be superior to existing ones and accepted by surgeons.
P/E of the market segment - Therapeutic medical equipment
Avinger developed and commercialized the first and only atherectomy system (plaque removal from blood vessels) that allows physicians to visualize the inside of an artery during the procedure. This chart shows the average rating for the therapeutic device sector, reflecting how the market values innovative technologies that improve treatment outcomes for peripheral arterial disease.
P/E of the market as a whole
Avinger develops and markets catheter-based medical devices for the treatment of peripheral arterial disease. The company's technology uses optical coherence tomography to visualize blood vessels from the inside. This risk appetite chart helps understand how investors value innovative medical device companies.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Avinger Inc.
Avinger develops and markets catheter-based medical devices for the treatment of peripheral arterial disease. This graph reflects future revenue expectations, which depend on the adoption of its technologies in vascular surgery and competition from other treatment methods.
%20P%2FE%20Avinger%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Avinger-Inc.&v=1772641520449 "Chart of the company's future (projected) P/E Avinger Inc.")
Future (projected) P/E of the market segment - Therapeutic medical equipment
Avinger produces catheter-based medical devices for the treatment of peripheral arterial disease. This chart shows how investors view its innovative Lumivascular technology. It compares expectations for Avinger with other cardiovascular medical device manufacturers.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Therapeutic-medical-equipment&v=1772641520494 "Future (projected) P/E graph of the market segment - Therapeutic medical equipment")
Future (projected) P/E of the market as a whole
Avinger develops and markets catheter-based medical devices for the treatment of peripheral arterial disease. Adoption of their Lumivascular technology depends on physician acceptance and insurance reimbursement. The overall economic climate, illustrated in this graph, impacts hospital budgets and the pace of adoption of new medical technologies.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772641520521 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Avinger Inc.
Avinger, Inc. develops and markets catheter-based medical devices for the treatment of peripheral arterial disease. The company's financial results depend on sales of its systems and disposable catheters. This chart illustrates the company's progress in increasing surgical adoption of its technology and achieving operating profitability.
Profit of companies in the market segment - Therapeutic medical equipment
Avinger, Inc. develops and markets catheters for the treatment of peripheral arterial disease using real-time optical coherence tomography (OCT) technology. This graph, showing overall sector profitability, reflects the push toward minimally invasive procedures. Avinger's unique technology, which allows for "seeing" inside arteries, is impacting treatment standards.
Overall market profit
Avinger has developed catheter-based medical devices for the treatment of peripheral arterial disease. Its technology allows doctors to visualize the inside of an artery during the procedure. The company's success depends on the implementation of its innovative tools in clinical practice.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Avinger Inc.
Avinger develops and markets catheter-based medical devices for the treatment of peripheral arterial disease. Future revenue projections depend on physician adoption of its technology and the volume of procedures performed in hospitals.
%20profit%20of%20the%20company%20Avinger%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Avinger-Inc.&v=1772641520649 "Graph of future (projected) profit of the company Avinger Inc.")
Future (predicted) profit of companies in the market segment - Therapeutic medical equipment
Avinger develops and markets catheters with real-time imaging for the treatment of peripheral arterial disease. This chart shows revenue projections for the therapeutic medical device sector. It helps assess how the company's innovative technology for treating atherosclerosis compares to overall trends in vascular surgery.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Therapeutic-medical-equipment&v=1772641520737 "Graph of future (predicted) profits of companies in a market segment - Therapeutic medical equipment")
Future (predicted) profit of the market as a whole
Avinger develops and markets catheters for the treatment of peripheral arterial disease. Demand for its products is driven by medical necessity. However, the pace of adoption of new medical technologies depends on hospital budgets. This dynamic, reflecting the state of the economy, affects the financial capacity of medical institutions to invest in innovative equipment.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772641520811 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Avinger Inc.
Avinger, Inc. develops and markets catheter-based medical devices for the treatment of peripheral arterial disease. This metric, which correlates market capitalization with revenue, reflects its struggle for market share. It demonstrates how investors view its unique real-time imaging technology and its potential to increase sales to physicians.
P/S market segment - Therapeutic medical equipment
Avinger, Inc. develops and commercializes optical coherence tomography (OCT)-based catheters for the treatment of peripheral arterial disease. The company's devices allow doctors to visualize the inside of an artery during procedures. This chart reflects the market's willingness to pay for revenue in the medical device sector, demonstrating confidence in Avinger's technology.
P/S of the market as a whole
Avinger, Inc. develops and commercializes catheters with real-time imaging for the treatment of peripheral arterial disease. Lumivascular technology aims to improve the safety and effectiveness of these procedures. This chart helps understand how the market values companies with innovative medical devices.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Avinger Inc.
Avinger develops and markets catheter-based medical devices for the treatment of peripheral arterial disease. This chart shows how investors value the company based on its projected future sales. It reflects their confidence in its technology and ability to compete in the minimally invasive surgery market.
%20P%2FS%20Avinger%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Avinger-Inc.&v=1772641520969 "The graph of the company's future (projected) P/S Avinger Inc.")
Future (projected) P/S of the market segment - Therapeutic medical equipment
Avinger develops and markets catheter-based medical devices for the treatment of peripheral arterial disease. This chart shows the average estimated future revenue for therapeutic device manufacturers. It helps understand how the market views Avinger's unique Lumivascular technology and its ability to capture market share in a competitive market.
%20P%2FS%20market%20segment%20graph%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Therapeutic-medical-equipment&v=1772641521004 "Future (projected) P/S market segment graph - Therapeutic medical equipment")
Future (projected) P/S of the market as a whole
Avinger (AVGR) develops and markets catheter-based medical devices for the treatment of peripheral arterial disease. Demand for their products is driven by medical needs and is not affected by economic cycles. This chart does not reflect their potential in the field of minimally invasive surgery.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772641521071 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Avinger Inc.
This chart shows the revenue of Avinger, a company developing medical devices for the treatment of peripheral arterial disease. Revenue is generated from sales of its catheters, which allow doctors to visualize the inside of an artery during procedures. The growth reflects the adoption of its unique technology in hospitals.
Sales of companies in the market segment - Therapeutic medical equipment
Avinger, Inc. develops and markets catheter-based medical devices for the treatment of peripheral arterial disease. Its revenue breakdown shows how much of its revenue comes from disposable catheters and how much from related equipment, a typical model for medical device manufacturers.
Overall market sales
Avinger, Inc. develops and manufactures catheter-based medical devices for the treatment of peripheral arterial disease. Demand for its products depends on the number of procedures performed and the acceptance of its technology by physicians. This dynamic, reflecting the overall economic situation, impacts hospital budgets and patient acceptance of elective endovascular interventions.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Avinger Inc.
Avinger develops and markets catheter-based medical devices for the treatment of peripheral arterial disease. Sales depend on the adoption of its technology by surgeons. This chart shows analyst expectations for the vascular surgery market.
%20sales%20of%20the%20company%20Avinger%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Avinger-Inc.&v=1772641521220 "Schedule of future (projected) sales of the company Avinger Inc.")
Future (projected) sales of companies in the market segment - Therapeutic medical equipment
Avinger, Inc. developed the Pantheris system, the world's first atherectomy catheter system with real-time imaging for the treatment of peripheral arterial disease. This chart shows the forecast for the therapeutic medical device sector, reflecting the demand for minimally invasive technologies for the treatment of vascular diseases.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Therapeutic-medical-equipment&v=1772641521235 "Schedule of future (projected) sales of companies in the market segment - Therapeutic medical equipment")
Future (projected) sales of the market as a whole
This chart illustrating healthcare costs is important for Avinger. The company develops medical devices for the treatment of peripheral arterial disease. Demand for its innovative catheters depends on hospital budgets and their willingness to implement new technologies to improve patient outcomes.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772641521268 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Avinger Inc.
Avinger develops and markets catheters with imaging technology for the treatment of peripheral arterial disease. This chart shows financial results at the commercialization stage. Profitability depends on increasing the use of its devices by surgeons and adequate reimbursement from insurance companies.
Market segment marginality - Therapeutic medical equipment
Avinger develops and markets catheter-based medical devices for the treatment of peripheral arterial disease. Profitability depends on the implementation of its unique technology, which allows doctors to visualize inside arteries during procedures. This chart shows the average profitability in the sector, helping to assess the demand for Avinger's innovative products.
Market marginality as a whole
Avinger develops and markets catheters for the treatment of peripheral arterial disease. Demand for its innovative medical devices depends on their acceptance by physicians and hospitals. This trend, reflecting the overall economic situation, impacts the budgets of medical institutions, which determines their ability to purchase new, more expensive equipment.
Employees in the company, segment and market as a whole
Number of employees in the company Avinger Inc.
Avinger, Inc. develops and markets catheter-based medical devices for the treatment of peripheral arterial disease. This chart depicts the team's engineering and sales teams. The dynamics illustrate how the company is vying for market share, striving to convince physicians of the benefits of its unique vascular imaging technology.
Share of the company's employees Avinger Inc. within the market segment - Therapeutic medical equipment
Avinger developed Lumivascular atherectomy technology, which allows doctors to visualize the inside of an artery during plaque removal. This graph shows the company's share of the total number of specialists in the peripheral artery disease treatment niche. This reflects its unique technology and market competition.
Number of employees in the market segment - Therapeutic medical equipment
Avinger, Inc. develops and markets catheter-based medical devices for the treatment of peripheral arterial disease. This chart, showing employment in the therapeutic medical device sector, is important. The growing number of vascular surgeons and engineers working on minimally invasive technologies indicates a search for alternatives to open surgery.
Number of employees in the market as a whole
Avinger develops medical devices for the treatment of peripheral arterial disease. This overall employment chart reflects the number of patients with access to advanced medicine. Stable employment and good health insurance allow patients to access innovative, minimally invasive procedures made possible by Avinger technologies.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Avinger Inc. (AVGR)
Avinger (AVGR) is a company that produces laser-based medical catheters for the treatment of peripheral arterial disease (atherosclerosis). This business is based on intellectual capital (technology patents) and precision manufacturing. This metric reflects the high market valuation of their unique technology.
%20of%20the%20company%20Avinger%20Inc.%20(AVGR)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Avinger-Inc.-AVGR&v=1772641521912 "Chart of market capitalization per employee (in thousands of dollars) of the company Avinger Inc. (AVGR)")
Market capitalization per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Avinger develops and markets medical devices for the treatment of peripheral arterial disease. The company's value lies in its unique technology, which allows doctors to visualize the inside of an artery during procedures. This graph shows the market premium placed on medical technology innovations created by a small team of engineers.
%20by%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Therapeutic-medical-equipment&v=1772641521993 "Market capitalization per employee (in thousands of dollars) by market segment - Therapeutic medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
Avinger develops and markets catheter-based medical devices for the treatment of peripheral arterial disease. It is an innovative medical device company. Its high employee rating reflects the value of its unique technology, where a small team of engineers and clinicians creates instruments that offer new treatment options.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772641522055 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Avinger Inc. (AVGR)
Avinger is a company that produces medical catheters (Lumiwave) for the treatment of peripheral arterial disease (atherosclerosis). It's a medtech R&D company. This chart shows how much the company spends (negative profit) on each engineer and salesperson in an attempt to commercialize its technology and convince surgeons of its benefits.
%20Chart%20Avinger%20Inc.%20(AVGR)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Avinger-Inc.-AVGR&v=1772641522077 "Company Profit Per Employee (in thousands of dollars) Chart Avinger Inc. (AVGR)")
Profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Avinger, Inc. develops and markets catheter-based medical devices for the treatment of peripheral arterial disease. This chart shows the company's success in commercializing its innovative technologies. Growth will depend on the increasing number of physicians using their products and increased market penetration.
%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Therapeutic-medical-equipment&v=1772641522108 "Chart of profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
Avinger (AVGR) is a company that produces laser-based medical catheters (atherectomy technology) for the treatment of peripheral arterial disease. It is a MedTech company. The metric is likely low or negative, as the company incurs R&D costs and is attempting to commercialize its technology in a competitive environment.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772641522150 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Avinger Inc. (AVGR)
Avinger, Inc. develops and markets catheter-based medical devices for the treatment of peripheral arterial disease. This chart shows how successfully the company is commercializing its technology. The increase in revenue per employee indicates its adoption by surgeons and sales growth.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Avinger-Inc.-AVGR&v=1772641522206 "Sales chart per company employee Avinger Inc. (AVGR)")
Sales per employee in the market segment - Therapeutic medical equipment
Avinger develops imaging-guided catheters (OCT) for the treatment of peripheral arterial disease (atherosclerosis). It's a medical device R&D and manufacturing company. This graph shows their current stage of commercialization. Their team's success lies in their ability to convince surgeons to use their expensive technology.
Sales per employee for the market as a whole
Chimera Investment (CIM) is a mortgage REIT (mREIT). They don't own homes, but rather invest in a portfolio of mortgage assets, including mortgage-backed securities (MBS) and loans. This chart illustrates the mREIT structure: Chimera is externally managed, so it has virtually no employees. Income is generated by capital management. The ratio will be abnormally high, reflecting the structure rather than operational efficiency.
Short shares by company, segment and market as a whole
Shares shorted by company Avinger Inc. (AVGR)
Avinger (AVGR) produces devices for the treatment of peripheral artery disease (atherectomy). The company has a long history of losses. This chart shows the volume of short positions. The short positions reflect doubts that the company's technology can compete with the giants' products.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Avinger-Inc.-AVGR&v=1772641522423 "Short Shares Chart for the Company Avinger Inc. (AVGR)")
Shares shorted by market segment - Therapeutic medical equipment
Avinger (AVGR) develops medical catheters (Lumiwave) for the treatment of peripheral arterial disease (atherosclerosis). The chart below shows the overall short position in the medical device sector. It illustrates how skeptical investors are about the commercialization of new technologies in this competitive niche.
Shares shorted by the overall market
Avinger (AVGR) is an R&D company developing medical devices. It's a speculative bet. When this market fear indicator rises, investors' risk appetite plummets. They sell off unprofitable stocks like AVGR, whose fate depends on R&D and regulatory approval.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Avinger Inc. (AVGR)
For Avinger, this oscillator is a barometer of faith in their artery treatment technology. The company produces catheters (Lumivascular) to combat atherosclerosis "from the inside out." "Overheating" (above 70) occurs due to positive data or news from the FDA. Slow adoption by surgeons and a persistent shortage of funds lead to "oversold" (below 30).
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Avinger-Inc.-AVGR&v=1772641522630 "RSI 14 indicator chart for the company's stock Avinger Inc. (AVGR)")
RSI 14 Market Segment - Therapeutic medical equipment
Avinger is an artery "cleaner." Their specialty is *catheters* (Pantheris, Ocelot) with *"eyes"* (OCT imaging) for *plaque removal* (atherectomy) in *leg arterial disease* (PAD). The "Therapeutic medical equipment" (medtech) sector thrives on R&D. RSI_14_Seg shows whether the *entire* sector is "overbought." This helps differentiate: is rising AVGR their "niche" or a sign of *overheating*?
RSI 14 for the overall market
Avinger (AVGR) is a cash-burning biotech. This chart is its lifeline. During periods of market euphoria, investors are willing to "buy the dream" and fund unprofitable R&D projects. During moments of panic, the cash flow is turned off, and investors demand profits rather than promises, putting AVGR at risk of survival.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast AVGR (Avinger Inc.)
Avinger is a medical device manufacturer that developed Lumivascular catheters for image-guided treatment of peripheral arterial disease (PAD). This chart shows the analysts' average 12-month forecast, reflecting their view on how quickly surgeons will adopt this innovative technology.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-AVGR-Avinger-Inc.&v=1772641522696 "A chart showing analyst consensus forecasts for the expected stock price. AVGR (Avinger Inc.)")
The difference between the consensus estimate and the actual stock price AVGR (Avinger Inc.)
Avinger (AVGR) is an "artery cleaner." Their Lumivascular (Ocelot) catheter system allows surgeons to *see* plaque from inside the vessel and cut it away. This chart measures the gap between the current price and the consensus target price. It shows whether experts believe this unique technology can be used to treat peripheral artery disease (PAD).
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-AVGR-Avinger-Inc.&v=1772641522715 "A chart showing the difference between the consensus forecast and the actual stock price. AVGR (Avinger Inc.)")
Analyst consensus forecast for stock prices by market segment - Therapeutic medical equipment
Avinger (AVGR) is a medical device company that developed Lumivascular, a system that allows surgeons to "see" plaque inside arteries during atherectomy. This chart shows general expectations for the therapeutic medical device sector. It reflects whether experts believe there will be demand for this "visual" surgery.
Analysts' consensus forecast for the overall market share price
Avinger (AVGR) is a medical technology company that "looks" inside arteries. They have developed catheters (Lumivascular) that allow surgeons to "see" plaque and simultaneously remove it. This chart shows the overall risk appetite. It reflects the market's willingness to fund companies whose breakthrough medical technologies are competing for market share from the giants.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Avinger Inc.
Avinger is the eyes of vascular surgeons. Their signature product (Lumivascular) is the world's only atherectomy (plaque removal) platform that allows doctors to see (via OCT) inside an artery during the procedure. This graph summarizes their implementation history. It reflects their (very slow) growth in razor and blade sales and their struggle to survive.
AKIMA Market Segment Index - Therapeutic medical equipment
Avinger is a company fighting peripheral arterial disease. Their unique Lumivascular technology allows surgeons to visualize plaque inside arteries in real time during surgery. This graph compares their composite index to the sector, showing how their imaging technology outperforms the competition.
The AKIM Index for the overall market
Avinger is a MedTech company that produces optical coherence tomography (OCT) catheters for the treatment of peripheral arterial disease. This chart, which reflects the market average, provides context. It helps assess how this niche player in vascular surgery compares to overall macroeconomic trends.
